- Home
- TRUE vs CDXS Comparison
TRUE vs CDXS Comparison
Compare TRUE & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUE
- CDXS
- Stock Information
- Founded
- TRUE 2005
- CDXS 2002
- Country
- TRUE United States
- CDXS United States
- Employees
- TRUE N/A
- CDXS N/A
- Industry
- TRUE Computer Software: Programming Data Processing
- CDXS Major Chemicals
- Sector
- TRUE Technology
- CDXS Industrials
- Exchange
- TRUE Nasdaq
- CDXS Nasdaq
- Market Cap
- TRUE 213.8M
- CDXS 230.3M
- IPO Year
- TRUE 2014
- CDXS 2010
- Fundamental
- Price
- TRUE $1.69
- CDXS $2.49
- Analyst Decision
- TRUE Buy
- CDXS Buy
- Analyst Count
- TRUE 4
- CDXS 2
- Target Price
- TRUE $4.17
- CDXS $11.00
- AVG Volume (30 Days)
- TRUE 433.2K
- CDXS 1.1M
- Earning Date
- TRUE 04-28-2025
- CDXS 05-01-2025
- Dividend Yield
- TRUE N/A
- CDXS N/A
- EPS Growth
- TRUE N/A
- CDXS N/A
- EPS
- TRUE N/A
- CDXS N/A
- Revenue
- TRUE $175,598,000.00
- CDXS $59,345,000.00
- Revenue This Year
- TRUE $17.53
- CDXS $12.62
- Revenue Next Year
- TRUE $16.56
- CDXS $22.11
- P/E Ratio
- TRUE N/A
- CDXS N/A
- Revenue Growth
- TRUE 10.64
- CDXS N/A
- 52 Week Low
- TRUE $1.51
- CDXS $2.42
- 52 Week High
- TRUE $4.62
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- TRUE 32.40
- CDXS 36.23
- Support Level
- TRUE $1.51
- CDXS $2.43
- Resistance Level
- TRUE $1.77
- CDXS $3.04
- Average True Range (ATR)
- TRUE 0.11
- CDXS 0.21
- MACD
- TRUE 0.03
- CDXS 0.04
- Stochastic Oscillator
- TRUE 40.36
- CDXS 8.78
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.